Opthea

South Yarra, Australiawww.opthea.com1expert edge

Clinical-stage biopharmaceutical company developing innovative therapies for wet age-related macular degeneration and other retinal diseases using VEGF-C/D targeting technology.

Why interesting to a deal team

Board connection via ex-Fortrea executive demonstrates deep pharma services expertise. Relevant for assessing clinical development strategy and regulatory pathway in rare eye diseases.

Experts connected to this company

Anshul ThakralNon-executive board director since June 2023

Anshul Thakral

Chief Executive Officer

Fortrea

FounderNew York

As Fortrea's new CEO executing a high-stakes CRO turnaround, and a Carlyle-connected biotech dealmaker, he sits at the center of pharma-services consolidation and clinical outsourcing trends.

Sources

No name matchPrimary
opthea.com
No name matchPrimary
ir.opthea.com

Strongest evidenceNo name match2 public sourcesHow the grades work